Galantamine Hydrobromide

氢溴酸加兰他敏

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGalantamine Hydrobromide
Drug Alias NameGalanthamine加兰特敏galantaminagalantamineRazadyne ER +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsSchizophreniaAutistic DisorderCognition Disorders +[23] 
Global Approved IndicationsAlzheimer Disease
Approved Indications in ChinaAlzheimer Disease
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryCzechiaCanadaUnited States +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesEssential Pharma LtdClinigen LtdVanderbilt University Medical Center +[5] 
Inactive CompaniesNeurological Research CenterInstitut National De La Santé Et De La Recherche Médicale, France U979University Of Medicine And Dentistry Of New Jersey +[19] 
Active IndicationsVascular DiseasesAlzheimer DiseaseAIDS Dementia Complex
Inactive IndicationsSchizophreniaAutistic DisorderCognition Disorders +[20] 

Other Information

ATC CodeN06DA04
Related LinksWikipediaDrugBankKEGG